Don Monti Comprehensive Cancer Center at North Shore University Hospital

Summary

Don Monti Comprehensive Cancer Center at North Shore University Hospital is a medical facility located in New Hyde Park, New York. This center is recognized for care of Leukemia, Lung Cancer, Breast Cancer, Cancer, Acute Myelogenous Leukemia and other specialties. Don Monti Comprehensive Cancer Center at North Shore University Hospital is involved with conducting 99 clinical trials across 135 conditions. There are 5 research doctors associated with this hospital, such as Veena John, MD, Marina Frimer, MD, Joanna Rhodes, MD, and Kevin M. Sullivan.

Top PIs

Clinical Trials running at Don Monti Comprehensive Cancer Center at North Shore University Hospital

Cancer

Follicular Lymphoma

Non-Hodgkin's Lymphoma

Lung Cancer

Relapse

Multiple Myeloma

Solid Tumors

Renal Cell Carcinoma

Kidney Cancer

Non-Small Cell Lung Cancer

Telisotuzumab Vedotin vs. Docetaxel

for Non-Small Cell Lung Cancer

This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.

Recruiting

2 awards

Phase 3

12 criteria

ABBV-101

for Blood Cancers

This trial tests ABBV-101, a new drug for treating certain blood cancers, in adults who haven't responded to other treatments. It aims to find the safest dose and check if the drug can reduce cancer activity.

Recruiting

1 award

Phase 1

15 criteria

Targeted Therapy

for Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Recruiting

1 award

Phase 2

9 criteria